Gracecast Lung Cancer Audio
ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC (audio)
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:05:45
- Mais informações
Informações:
Sinopse
Dr. Edward Garon, David Geffen School of Medicine at UCLA, describes the exciting developments with LDK-378 and potentially other second generation ALK inhibitors for crizotinib-resistant ALK-positive advanced NSCLC.